TransMedics Group, Inc.
(NASDAQ: TMDX)

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

129.880 -

-3.420 (-2.57%)
价格区间 127.710 - 134.520   (5.33%)
开盘 133.000
昨收 133.300
127.500
买盘 40
135.000
卖盘 200
成交量 506,815
成交额 58,390,299
注释 -
数据延迟。最后一次更新13 Feb 2026 05:40.
数据提供商
查看所有活动


Loading Chart...

Please login to view stock data and analysis